159 related articles for article (PubMed ID: 37498119)
1. New boundaries for fertility sparing management in endometrial cancer.
Rodolakis A; Pergialiotis V; Thomakos N
Curr Opin Oncol; 2023 Sep; 35(5):394-400. PubMed ID: 37498119
[TBL] [Abstract][Full Text] [Related]
2. Fertility-sparing approach for endometrial cancer: the role of office hysteroscopy.
Carugno J; Wong A
Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):296-303. PubMed ID: 34292797
[TBL] [Abstract][Full Text] [Related]
3. Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of Tuebingen.
Andress J; Pasternak J; Walter C; Kommoss S; Krämer B; Hartkopf A; Brucker SY; Schönfisch B; Steinmacher S
Arch Gynecol Obstet; 2021 Jul; 304(1):215-221. PubMed ID: 33606091
[TBL] [Abstract][Full Text] [Related]
4. Updates on Conservative Management of Endometrial Cancer.
Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
[TBL] [Abstract][Full Text] [Related]
5. [Fertility sparing treatment of endometrial carcinoma].
Luijten MMW; van Weelden WJ; de Kroon CD; Pijnenborg JMA; van Gent MDJM
Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129891
[TBL] [Abstract][Full Text] [Related]
6. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
7. The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Ou YC; Fu HC; Lan J; Wu CH; Kung FT; Lan KC; Tsai YC; Lin H
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():99-104. PubMed ID: 34739876
[TBL] [Abstract][Full Text] [Related]
8. Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Lago V; Marina T; Laseca Modrego M; Gil-Ibañez B; Rodriguez JR; Domingo J; Minig L; Padilla-Iserte P; Arencibia Sánchez O; Sala Ferichola M; Munmanny M; Martín Salamanca B; Iacoponi S; Cabrera S; Coronado P; Utrilla-Layna J; Bataller Á; Fiol G; Corbalán S; Espinosa E; Gil-Moreno A; Domingo S;
Arch Gynecol Obstet; 2022 Sep; 306(3):821-828. PubMed ID: 35122158
[TBL] [Abstract][Full Text] [Related]
9. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
10. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L
Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012
[TBL] [Abstract][Full Text] [Related]
11. Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review.
Gurgan T; Bozdag G; Demirol A; Ayhan A
Reprod Biomed Online; 2007 Nov; 15(5):561-5. PubMed ID: 18028748
[TBL] [Abstract][Full Text] [Related]
12. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer.
Arora V; Quinn MA
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):311-24. PubMed ID: 22277287
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
15. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
[TBL] [Abstract][Full Text] [Related]
16. [Conservative treatments for endometrial cancer].
Eid M; Gonthier C; Bucau M; Koskas M
Rev Prat; 2022 Sep; 72(7):747-749. PubMed ID: 36511962
[TBL] [Abstract][Full Text] [Related]
17. Conservative management of endometrial cancer: a survey amongst European clinicians.
La Russa M; Zapardiel I; Halaska MJ; Zalewski K; Laky R; Dursun P; Lindquist D; Sukhin V; Polterauer S; Biliatis I
Arch Gynecol Obstet; 2018 Aug; 298(2):373-380. PubMed ID: 29943129
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
Guillon S; Popescu N; Phelippeau J; Koskas M
Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.
Mitsuhashi A; Sato Y; Kiyokawa T; Koshizaka M; Hanaoka H; Shozu M
Ann Oncol; 2016 Feb; 27(2):262-6. PubMed ID: 26578736
[TBL] [Abstract][Full Text] [Related]
20. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
